Biomanufacturing

eXoZymes Partners With B2i Digital to Showcase Cell-Free Biomanufacturing Platform

eXoZymes Partners With B2i Digital to Showcase Cell-Free Biomanufacturing Platform

eXoZymes Inc. has been selected as a B2i Digital Featured Company, highlighting its cell-free, AI-guided enzyme platform that offers a scalable alternative to traditional petrochemical processes and synthetic biology methods.

October 14, 2025
GeoVax's New Vaccine Manufacturing Process Could Revolutionize Global Access to Critical Vaccines

GeoVax's New Vaccine Manufacturing Process Could Revolutionize Global Access to Critical Vaccines

GeoVax Labs has developed an advanced manufacturing process for MVA vaccines that eliminates dependency on pathogen-free eggs, potentially transforming vaccine production capabilities worldwide while reducing costs and increasing accessibility.

February 4, 2025